...
首页> 外文期刊>Coronary artery disease >Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori.
【24h】

Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori.

机译:幽门螺杆菌CagA阳性菌株感染患者的冠状动脉粥样硬化负担。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: Cytotoxic associated gene-A (CagA)-positive strains of Helicobacter pylori emerged as a possible atherosclerotic stimulus. Nevertheless, whether CagA-positivity is associated with more extensive or severe atherosclerotic coronary burden has never been studied. METHODS: Forty consecutive patients with coronary artery disease (CAD) and twenty consecutive patients with normal coronary arteries undergoing coronary angiography were enrolled. All patients underwent evaluation of classical atherogenic risk factors and assessment of anti-urease B and anti-CagA antibodies titer. Either the severity of coronary stenosis (stenosis score) or the extent of coronary atherosclerosis (extent score) was evaluated in CAD patients. RESULTS: The anti-CagA antibody titer was significantly higher in patients with CAD as compared with normal coronary arteries patients [85 (10-108.75) vs. 47.3 (17-64) RU/ml, P=0.02], whereas there were no differences in anti-urease B titer between the two groups. A significant correlation was found between anti-CagA antibody titer and extent score (R=0.35, P=0.03), whereas stenosis score was similar (R=0.25, P=0.11). On the contrary, no significant correlation was found between anti-urease B antibody titer and either extent or stenosis score. Moreover, CagA-positive patients had a more extensive CAD (P=0.029) when compared with CagA-negative patients. Interestingly, whereas serum glucose, LDL levels, anti-urease B, and anti-CagA antibodies were predictors of extent score at univariate analysis, at multivariate analysis anti-CagA antibody titer only was an independent predictor of the extent of coronary atherosclerosis (B=0.051, standard error of B=0.042, P=0.04). CONCLUSION: These results support the association between CagA-positive H. pylori infection and coronary atherosclerotic burden. Further studies are needed to better elucidate the mechanism by which CagA-positive strains may promote atherosclerosis.
机译:目的:幽门螺杆菌的细胞毒相关基因A(CagA)阳性菌株出现可能是动脉粥样硬化的刺激。但是,从未研究过CagA阳性与更广泛或更严重的动脉粥样硬化性冠状动脉负担有关。方法:连续入选40例冠状动脉疾病(CAD)患者和20例连续进行冠状动脉造影的正常冠状动脉患者。所有患者均接受经典动脉粥样硬化危险因素的评估以及抗脲酶B和抗CagA抗体效价的评估。在CAD患者中评估了冠状动脉狭窄的严重程度(狭窄评分)或冠状动脉粥样硬化的程度(程度评分)。结果:与正常冠状动脉患者相比,CAD患者的抗CagA抗体滴度明显更高[85(10-108.75)vs. 47.3(17-64)RU / ml,P = 0.02],而没有两组之间抗脲酶B效价的差异。发现抗CagA抗体滴度和程度评分之间存在显着相关性(R = 0.35,P = 0.03),而狭窄评分相似(R = 0.25,P = 0.11)。相反,在抗脲酶B抗体滴度与程度或狭窄评分之间未发现显着相关性。此外,与CagA阴性患者相比,CagA阳性患者具有更广泛的CAD(P = 0.029)。有趣的是,在单变量分析中,血清葡萄糖,LDL水平,抗尿酶B和抗CagA抗体是程度得分的预测指标,而在多变量分析中,抗CagA抗体滴度仅是冠状动脉粥样硬化程度的独立指标(B = 0.051,标准误为B = 0.042,P = 0.04)。结论:这些结果支持CagA阳性幽门螺杆菌感染与冠状动脉粥样硬化负担之间的关联。需要进一步研究以更好地阐明CagA阳性菌株可能促进动脉粥样硬化的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号